Stocks · Health care · Pharmaceutical Preparations

HARROW, INC.

HROW Clue Score59
United States Fiscal year ends December CIK 0001360214 Results filed 10 Aug 2026

What the insiders did Net selling

By person

7 insiders · 13 transactions
158×

Mark L. Baum holds 158 times base salary in stock. $119.85M of shares against $754.91K in salary for 2025.

Salary from the company's own proxy. The shares are what Mark L. Baum last reported holding, valued at $40.00, the price Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Opaleye Management Inc. entity
10% owner
—
$9.18M (6)
−$9.18M
59,428
0.1585%
$2.38M
−83.9%
Amir Shojaei
Chief Scientific Officer
—
$450.00K (1) scheduled
−$450.00K
0
0.0000%
$0.00
—
Mark L Baum
Chief Executive Officer
$302.00K (1)
—
+$302.00K
2,996,130
7.99%
$119.85M
+40.2%
Andrew R. Boll
President and CFO
$104.65K (1)
—
+$104.65K
814,679
2.17%
$32.59M
+43.4%
Adrienne L Graves
Director
$31.07K (1)
—
+$31.07K
1,000
0.0027%
$40.00K
—
Lauren P Silvernail
Director
$31.00K (1)
—
+$31.00K
1,000
0.0027%
$40.00K
—
John P. Saharek
CEO & President, ImprimisRx
—
—
—
467,388
1.25%
$18.70M
+56.0%